Three-Year Retention in Buprenorphine Treatment for Opioid Use Disorder Among Privately Insured Adults

Abstract

Buprenorphine treatment retention declined markedly in the first year and was substantially lower than in comparable studies from publicly funded health care systems, apparently largely due to disenrollment. The association of psychotherapy with greater retention suggests that it may be an important complement to opioid agonist treatment.